AS

Anju Singh Parmar

Active Director Director DIN 07276033
DIN 07276033 First appointment Sep 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2015
Shareholding value •••• Premium profile

About Anju Singh Parmar

Data last updated:

Anju Singh Parmar is a Director at Growth Pharmaceutical Private Limited (since 2015). The company operates in Pharma. Growth Pharmaceutical Private Limited reported revenue of ₹1.70 Cr (FY 2025).

DIN 07276033
Primary Designation Director
Industry Pharma
First Appointment 11 Sep 2015
Oldest Company Age 11 yrs
Largest company Growth Pharmaceutical Private Limited · ₹1.70 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Sep 20152015₹1.70 Cr (FY 2025)Active

Board colleagues of Anju Singh Parmar

NameDINCompanyDesignation
Abhishek Singh08471365Growth Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Growth Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Anju Singh Parmar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anju Singh Parmar

Anju Singh Parmar currently holds 1 directorship: Growth Pharmaceutical Private Limited (Director, since 11 Sep 2015, revenue ₹1.70 Cr (FY 2025)).

Anju Singh Parmar was first appointed on 11 Sep 2015 as Director at Growth Pharmaceutical Private Limited.

The current boards of Anju Singh Parmar's companies include Abhishek Singh (Growth Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available